Literature DB >> 2694235

The place of lung 99mTc DTPA aerosol transfer in the investigation of lung infections in HIV positive patients.

M J O'Doherty1, C J Page, C S Bradbeer, M Shahmanesh, A Edwards, D Barlow, T O Nunan, N T Bateman.   

Abstract

Pneumocystis carinii pneumonia (PCP) is the most common cause of pneumonia in HIV antibody positive patients, but other pneumonias remain important, i.e. streptococcal and mycobacterial infections. A definitive diagnosis relies on obtaining samples from the lung either noninvasively (induced sputum), or invasively (bronchoalveolar lavage, transbronchial or open lung biopsy). We have used the noninvasive technique of nebulized 99mTc DTPA transfer, to assess patients with PCP (n = 30) and other lung infections (n = 20) to see whether this test will distinguish between the various infections. The presence of a biphasic, rapid transfer curve indicates severe extensive alveolar damage and is seen in PCP or legionella pneumonia. The mean transfer time (T50 +/- SEM) for patients with PCP (whether smokers or nonsmokers) was 2.1 +/- 0.2 min, and for two of the patients with legionella 3.2 min. In PCP effective treatment causes the transfer to slow (mean T50 22.7 +/- 3.3 min, n = 24) and become monoexponential. Other causes of these changes in transfer are discussed. The other pneumonias (streptococcal, mycobacterial, and staphylococcal) did not result in biphasic curves or very rapid times, their T50 values are indistinguishable from cigarette smokers. In this patient group the DTPA transfer is a useful noninvasive investigation with a very rapid, biphasic curve indicating a high probability of PCP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2694235     DOI: 10.1016/s0954-6111(89)80071-x

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  Diagnostic value of lung clearance of 99mTc DTPA compared with other non-invasive investigations in Pneumocystis carinii pneumonia in AIDS.

Authors:  M J O'Doherty; C J Page; T O Nunan; N T Bateman
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

2.  British Thoracic Society summer meeting. 11-13 July 1990, Birmingham. Abstracts.

Authors: 
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

3.  Optimising technetium 99m diethylene triamine penta-acetate lung clearance in patients with the acquired immunodeficiency syndrome.

Authors:  H Van der Wall; I P Murray; P D Jones; D W Mackey; B M Walker; P Monaghan
Journal:  Eur J Nucl Med       Date:  1991

4.  Diagnostic value of lung clearance of 99mTc DTPA compared with other non-invasive investigations in Pneumocystis carinii pneumonia in AIDS.

Authors:  D S Robinson; D A Cunningham; S Dave; J Fleming; D M Mitchell
Journal:  Thorax       Date:  1991-10       Impact factor: 9.139

5.  Different kinetics of lung clearance of technetium-99m labelled diethylene triamine penta-acetic acid in patients with sarcoidosis and smokers.

Authors:  I Brådvik; P Wollmer; E Evander; H Lárusdóttir; B Blom-Bülow; B Jonson
Journal:  Eur J Nucl Med       Date:  1994-11

Review 6.  Pulmonary technetium-99m diethylene triamine penta-acetic acid aerosol clearance as an index of lung injury.

Authors:  M J O'Doherty; A M Peters
Journal:  Eur J Nucl Med       Date:  1997-01

Review 7.  Pulmonary nuclear medicine.

Authors:  R F Miller; M J O'Doherty
Journal:  Eur J Nucl Med       Date:  1992
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.